Intention to initiate and uptake of PrEP among women who injects drugs in a demonstration project: an application of the theory of planned behavior

References

• Ajzen, I. (1985). From intentions to actions: A theory of planned behavior. In Action control (pp. 11–39). Springer. https://doi.org/10.1007/978-3-642-69746-3_2
   Google Scholar
• Ajzen, I., & Driver, B. L. (1992). Contingent value measurement: On the nature and meaning of willingness to pay. Journal of Consumer Psychology, 1(4), 297–316. https://doi.org/10.1016/S1057-7408(08)80057-5
   Google Scholar
• Allen, S. T., O’Rourke, A., White, R. H., Smith, K. C., Weir, B., Lucas, G. M., Sherman, S. G., & Grieb, S. M. (2019). Barriers and facilitators to PrEP use among people who inject drugs in rural Appalachia: A qualitative study. AIDS and Behavior, https://doi.org/10.1007/s10461-019-02767-3
   Google Scholar
• Auerbach, J. D., Kinsky, S., Brown, G., & Charles, V. (2015). Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among us women at risk of acquiring HIV. AIDS Patient Care and STDs, 29(2), 102–110. https://doi.org/10.1089/apc.2014.0142
   PubMed Web of Science ®Google Scholar
• Bazzi, A. R., Biancarelli, D. L., Childs, E., Drainoni, M.-L., Edeza, A., Salhaney, P., Mimiaga, M. J., & Biello, K. B. (2018). Limited Knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs. AIDS Patient Care and STDs, 32(12), 529–537. https://doi.org/10.1089/apc.2018.0126
   PubMed Web of Science ®Google Scholar
• Biello, K. B., Bazzi, A. R., Mimiaga, M. J., Biancarelli, D. L., Edeza, A., Salhaney, P., Childs, E., & Drainoni, M. L. (2018). Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduction Journal, 15(1), 55. https://doi.org/10.1186/s12954-018-0263-5
   PubMed Web of Science ®Google Scholar
• Bogart, L. M., Kral, A. H., Scott, A., Anderson, R., Flynn, N., Gilbert, M. L., & Bluthenthal, R. N. (2005). Condom attitudes and behaviors among injection drug users participating in California syringe exchange programs. AIDS and Behavior, 9(4), 423–432. https://doi.org/10.1007/s10461-005-9014-1
   PubMed Web of Science ®Google Scholar
• Bova, C., Route, P. S., Fennie, K., Ettinger, W., Manchester, G. W., & Weinstein, B. (2012). Measuring patient-provider trust in a primary care population: Refinement of the health care relationship trust scale. Research in Nursing and Health, 35(4), 397–408. https://doi.org/10.1002/nur.21484
   PubMed Web of Science ®Google Scholar
• Braksmajer, A., Fedor, T. M., Chen, S. R., Corales, R., Holt, S., Valenti, W., & McMahon, J. M. (2018). Willingness to take prep for HIV prevention: The combined effects of race/ethnicity and provider trust. AIDS Education and Prevention, 30(1), 1–12. https://doi.org/10.1521/aeap.2018.30.1.1
   PubMed Web of Science ®Google Scholar
• Brazil, K., Ozer, E., Cloutier, M. M., Levine, R., & Stryer, D. (2005). From theory to practice: Improving the impact of health services research. BMC Health Services Research, 5(1), 1. https://doi.org/10.1186/1472-6963-5-1
   PubMedGoogle Scholar
• Center for Disease Control and Prevention. (2018). HIV surveillance report, 2017. 29. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
   Google Scholar
• Centers for Disease Control and Prevention, U. P. H. S. (2018). Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: a clinical practice guideline.
   Google Scholar
• Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., Chuachoowong, R., Gvetadze, R. J., McNicholl, J. M., Paxton, L. A., Curlin, M. E., Hendrix, C. W., & Vanichseni, S. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir study): A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 381(9883), 2083–2090. https://doi.org/10.1016/S0140-6736(13)61127-7
   PubMed Web of Science ®Google Scholar
• Davey-Rothwell, M. A., & Latkin, C. A. (2007). Gender differences in social network influence among injection drug users: Perceived norms and needle sharing. Journal of Urban Health, 84(5), 691–703. https://doi.org/10.1007/s11524-007-9215-1
   PubMed Web of Science ®Google Scholar
• Davis, R., Campbell, R., Hildon, Z., Hobbs, L., & Michie, S. (2015). Theories of behaviour and behaviour change across the social and behavioural sciences: A scoping review. Health Psychology Review, 9(3), 323–344. https://doi.org/10.1080/17437199.2014.941722
   PubMed Web of Science ®Google Scholar
• Edelman, E. J., Moore, B. A., Calabrese, S. K., Berkenblit, G., Cunningham, C., Patel, V., Phillips, K., Tetrault, J. M., Shah, M., Fiellin, D. A., & Blackstock, O. (2017). Primary care physicians’ willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs. AIDS and Behavior, 21(4), 1025–1033. https://doi.org/10.1007/s10461-016-1612-6
   PubMed Web of Science ®Google Scholar
• Eisingerich, A. B., Wheelock, A., Gomez, G. B., Garnett, G. P., Dybul, M. R., & Piot, P. K. (2012). Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: A multinational study. PLoS One, 7(1), e28238. https://doi.org/10.1371/journal.pone.0028238
   PubMed Web of Science ®Google Scholar
• El-Bassel, N., Shaw, S. A., Dasgupta, A., & Strathdee, S. A. (2014a). Drug use as a driver of HIV risks: Re-emerging and emerging issues. In Current opinion in HIV and AIDS (Vol. 9, Issue 2, pp. 150–155). Curr Opin HIV AIDS. https://doi.org/10.1097/COH.0000000000000035
   Google Scholar
• El-Bassel, N., Shaw, S. A., Dasgupta, A., & Strathdee, S. A. (2014b). People who inject drugs in intimate relationships: It takes two to combat HIV. Current HIV/AIDS Reports, 11(1), 45–51. https://doi.org/10.1007/s11904-013-0192-6
   PubMed Web of Science ®Google Scholar
• Felsher, M., Ziegler, E., Smith, L. R., Sherman, S. G., Amico, K. R., Fox, R., Madden, K., & Roth, A. M. (2020). An exploration of pre-exposure prophylaxis (PrEP) initiation among women who inject drugs. Archives of Sexual Behavior, 49(6), 2205–2212. https://doi.org/10.1007/s10508-020-01684-0
   PubMed Web of Science ®Google Scholar
• Fishbein, M. (2000). The role of theory in HIV prevention. AIDS Care – Psychological and Socio-Medical Aspects of AIDS/HIV, 12(3), 273–278. https://doi.org/10.1080/09540120050042918
   PubMed Web of Science ®Google Scholar
• Glick, J. L., Russo, R., Jivapong, B., Rosman, L., Pelaez, D., Footer, K. H. A., & Sherman, S. G. (2020). The PrEP care continuum among cisgender women who sell sex and/or use drugs globally: A systematic review. AIDS and Behavior, 24(5), 1312–1333. https://doi.org/10.1007/s10461-019-02733-z
   PubMed Web of Science ®Google Scholar
• Golub, S. A., Gamarel, K. E., Rendina, H. J., Surace, A., & Lelutiu-Weinberger, C. L. (2013). From efficacy to effectiveness: Facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care and STDs, 27(4), 248–254. https://doi.org/10.1089/apc.2012.0419
   PubMed Web of Science ®Google Scholar
• Jackson, T., Huang, A., Chen, H., Gao, X., Zhang, Y., & Zhong, X. (2013). Predictors of willingness to use HIV pre-exposure prophylaxis among female sex workers in Southwest China. AIDS Care, 25(5), 601–605. https://doi.org/10.1080/09540121.2012.726341
   PubMed Web of Science ®Google Scholar
• Knight, R., Small, W., Carson, A., & Shoveller, J. (2016). Complex and Conflicting social norms: Implications for implementation of future HIV pre-exposure prophylaxis (PrEP) interventions in Vancouver, Canada. Plos One, 11(1), e0146513. https://doi.org/10.1371/journal.pone.0146513
   PubMed Web of Science ®Google Scholar
• Kuo, I., Olsen, H., Patrick, R., Phillips, G., Magnus, M., Opoku, J., Rawls, A., Peterson, J., Hamilton, F., Kharfen, M., & Greenberg, A. (2016). Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. Drug and Alcohol Dependence, 164, 8–13. https://doi.org/10.1016/j.drugalcdep.2016.02.044
   PubMed Web of Science ®Google Scholar
• Lansky, A., Finlayson, T., Johnson, C., Holtzman, D., Wejnert, C., Mitsch, A., Gust, D., Chen, R., Mizuno, Y., & Crepaz, N. (2014). Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLoS One, 9(5), e97596. https://doi.org/10.1371/journal.pone.0097596
   PubMed Web of Science ®Google Scholar
• Mimiaga, M. J., Case, P., Johnson, C. V., Safren, S. A., & Mayer, K. H. (2009). Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: Limited knowledge and experience but potential for increased utilization after education. Journal of Acquired Immune Deficiency Syndromes, 50(1), 77–83. https://doi.org/10.1097/QAI.0b013e31818d5a27
   PubMed Web of Science ®Google Scholar
• Myers, B., Fakier, N., & Louw, J. (2009). Stigma, treatment beliefs, and substance abuse treatment use in historically disadvantaged communities. African Journal of Psychiatry (South Africa), 12(3), 218–222. https://doi.org/10.4314/ajpsy.v12i3.48497
   PubMed Web of Science ®Google Scholar
• Pinto, R. M., Lacombe-Duncan, A., Kay, E. S., & Berringer, K. R. (2019). Expanding knowledge about implementation of pre-exposure prophylaxis (PrEP): A methodological review. AIDS and Behavior, 23(10), 2761–2778. https://doi.org/10.1007/s10461-019-02577-7
   PubMed Web of Science ®Google Scholar
• Rivet, K., Chris Balthazar, A., Coggia, T., & Hosek, S. (n.d.). Audio visual representation (PrEP REP): Development and pilot of a PrEP education video.
   Google Scholar
• Roth, A., Felsher, M., Tran, N., Bellamy, S., Martinez-Donate, A., Krakower, D., & Szep, Z. (2019). Drawing from the theory of planned behaviour to examine pre-exposure prophylaxis uptake intentions among heterosexuals in high HIV prevalence neighbourhoods in Philadelphia, Pennsylvania, USA: An observational study. Sexual Health, 16(3), 218–224. https://doi.org/10.1071/SH18081
   PubMed Web of Science ®Google Scholar
• Roth, A. M., Tran, N. K., Felsher, M. A., Gadegbeku, A. B., Piecara, B., Fox, R., Krakower, D. S., Bellamy, S. L., Amico, K. R., Benitez, J. A., & Van Der Pol, B. (2020). Integrating HIV pre-exposure prophylaxis with community-based syringe services for women who inject drugs: Results from the project SHE demonstration study. JAIDS Journal of Acquired Immune Deficiency Syndromes, https://doi.org/10.1097/QAI.0000000000002558
   Google Scholar
• Sherman, S. G., Schneider, K. E., Nyeong Park, J., Allen, S. T., Hunt, D., Chaulk, C. P., & Weir, B. W. (2019). PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug and Alcohol Dependence, 195, 148–155. https://doi.org/10.1016/j.drugalcdep.2018.08.014
   PubMed Web of Science ®Google Scholar
• Shrestha, R., & Copenhaver, M. (2018). Exploring the use of pre-exposure prophylaxis (PrEP) for HIV prevention among high-risk people who use drugs in treatment. Frontiers in Public Health, 6, https://doi.org/10.3389/fpubh.2018.00195
   Google Scholar
• Stein, M., Thurmond, P., & Bailey, G. (2014). Willingness to use HIV pre-exposure prophylaxis among opiate users. AIDS and Behavior, 18(9), 1694–1700. https://doi.org/10.1007/s10461-014-0778-z
   PubMed Web of Science ®Google Scholar
• Walters, S. M., Reilly, K. H., Neaigus, A., & Braunstein, S. (2017). Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: The importance of networks and syringe exchange programs for HIV prevention. Harm Reduction Journal, 14(1), https://doi.org/10.1186/s12954-017-0166-x
   Google Scholar
• Wang, Z., Lau, J. T. F., Yang, X., Cai, Y., Gross, D. L., Ma, T., & Liu, Y. (2017). Acceptability of daily use of free oral pre-exposure prophylaxis (PrEP) among transgender women sex workers in Shenyang, China. AIDS and Behavior, 21(12), 3287–3298. https://doi.org/10.1007/s10461-017-1869-4
   PubMed Web of Science ®Google Scholar
• Wang, Z., Mo, P. K. H., Ip, M., Fang, Y., & Lau, J. T. F. (2020). Uptake and willingness to use PrEP among Chinese gay, bisexual and other men who have sex with men with experience of sexualized drug use in the past year. BMC Infectious Diseases, 20(1), 299. https://doi.org/10.1186/s12879-020-05024-4
   PubMed Web of Science ®Google Scholar
• Washington, D. L., Bean-Mayberry, B., Riopelle, D., & Yano, E. M. (2011). Access to care for women veterans: Delayed healthcare and unmet need. Journal of General Internal Medicine, 26(Suppl 2), 655–661. https://doi.org/10.1007/s11606-011-1772-z
   PubMed Web of Science ®Google Scholar
• Whiteside, Y. O., Harris, T., Scanlon, C., Clarkson, S., & Duffus, W. (2011). Self-perceived risk of HIV infection and attitudes about preexposure prophylaxis among sexually transmitted disease clinic attendees in South Carolina. AIDS Patient Care and STDs, 25(6), 365–370. https://doi.org/10.1089/apc.2010.0224
   PubMed Web of Science ®Google Scholar
• Worth, D. (1989). Sexual decision-making and AIDS: Why condom promotion among vulnerable women is likely to fail. Studies in Family Planning, 20(6), 297. https://doi.org/10.2307/1966433
   PubMed Web of Science ®Google Scholar
• Young, I., Flowers, P., & McDaid, L. M. (2014). Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: Findings from a qualitative study in Scotland. BMJ Open, 4(11), e005717. https://doi.org/10.1136/bmjopen-2014-005717
   PubMed Web of Science ®Google Scholar